These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism--effect of octreotide therapy. Schoof E, Dörr HG, Kiess W, Lüdecke DK, Freitag E, Zindel V, Rascher W, Dötsch J. Horm Res; 2004; 61(4):184-9. PubMed ID: 14739526 [Abstract] [Full Text] [Related]
11. Spontaneous endocrine cure of gigantism due to pituitary apoplexy. Arisaka O, Hall R, Hughes IA. Br Med J (Clin Res Ed); 1983 Oct 08; 287(6398):1007-8. PubMed ID: 6311318 [Abstract] [Full Text] [Related]
12. Management of type 2 diabetes mellitus associated with pituitary gigantism. Ali O, Banerjee S, Kelly DF, Lee PD. Pituitary; 2007 Oct 08; 10(4):359-64. PubMed ID: 17629784 [Abstract] [Full Text] [Related]
14. Familial X-Linked Acrogigantism: Postnatal Outcomes and Tumor Pathology in a Prenatally Diagnosed Infant and His Mother. Wise-Oringer BK, Zanazzi GJ, Gordon RJ, Wardlaw SL, William C, Anyane-Yeboa K, Chung WK, Kohn B, Wisoff JH, David R, Oberfield SE. J Clin Endocrinol Metab; 2019 Oct 01; 104(10):4667-4675. PubMed ID: 31166600 [Abstract] [Full Text] [Related]
15. Eight-year follow-up of a child with a GH/prolactin-secreting adenoma: efficacy of pegvisomant therapy. Bergamaschi S, Ronchi CL, Giavoli C, Ferrante E, Verrua E, Ferrari DI, Lania A, Rusconi R, Spada A, Beck-Peccoz P. Horm Res Paediatr; 2010 Oct 01; 73(1):74-9. PubMed ID: 20190543 [Abstract] [Full Text] [Related]
17. Pituitary gigantism caused by growth hormone excess from infancy. Gelber SJ, Heffez DS, Donohoue PA. J Pediatr; 1992 Jun 01; 120(6):931-4. PubMed ID: 1593354 [Abstract] [Full Text] [Related]
18. [Outcome of somatostatin analogue treatment in acromegaly]. Mondok A, Tóth M, Patócs A, Szücs N, Igaz P, Pusztai P, Czirják S, Beko G, Gláz E, Rácz K, Tulassay Z. Orv Hetil; 2009 Aug 02; 150(31):1457-62. PubMed ID: 19617182 [Abstract] [Full Text] [Related]
19. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation. Zimmerman D, Young WF, Ebersold MJ, Scheithauer BW, Kovacs K, Horvath E, Whitaker MD, Eberhardt NL, Downs TR, Frohman LA. J Clin Endocrinol Metab; 1993 Jan 02; 76(1):216-22. PubMed ID: 8421089 [Abstract] [Full Text] [Related]